Partial Aortic Valve Fusion Induced by Left Ventricular Assist Device
|
|
- Darren McDowell
- 5 years ago
- Views:
Transcription
1 Partial Aortic Valve Fusion Induced by Left Ventricular Assist Device Alan G. Rose, MD, Soon J. Park, MD, Alan J. Bank, MD, and Leslie W. Miller, MD Department of Laboratory Medicine and Pathology, Division of Cardiovascular and Thoracic Surgery, and Division of Cardiology, University of Minnesota and Fairview-University Medical Center, Minneapolis, Minnesota Background. Left ventricular assist devices (LVADs) may be used (1) as a bridging device to cardiac transplantation, (2) for permanent replacement of left ventricular function, and (3) as a bridge to recovery of ventricular function, for example, in recoverable myocardial disease. In this third group of patients, it is important that the LVAD does not produce changes in the heart that will have a deleterious effect on cardiac function once the device is removed. Furthermore, if the LVAD fails, survival depends on optimal function of the diseased heart. Methods. All hearts with LVADs encountered as surgical specimens following heart transplantation or at autopsy at the Fairview-University of Minnesota Medical Center during the 5-month period August 1998 to January 1999 were examined for native valvular heart disease. The nature and extent of commissural fusion was noted and measured. Light microscopy was performed on any valve lesions. Results. Four of 6 patients with HeartMate (Thermo Cardiosystems, Inc, Woburn, MA) LVADs showed evidence of commissural fusion (acquired aortic stenosis). In 1 patient, this condition was caused by an organizing thrombus uniting a 14-mm length of the commissural region of the right coronary and noncoronary cusps of the aortic valve. Fibrous commissural fusion due to totally organized thrombus in the other 3 patients affected one aortic commissure (2 patients, 2 mm and 4 mm, respectively) and two commissures (1 patient, 2 mm and 5 mm). Partial cuspal fusion in each case was due to permanent closure of the native aortic valve induced by the LVAD s operating in its automatic setting. Mean length of commissural fusion was 5.4 mm (range, 2 to 14 mm; standard deviation [SD] 5.0 mm). Mean duration of implantation of the six LVADs was days (range, 26 to 689 days; SD days). The LVADs of the 3 patients with fibrous fusion of the commissures had been implanted for an average of days (range, 26 to 689 days; SD days). Conclusions. Normal function of the LVAD produces permanent closure of the native aortic valve. Stasis on the ventricular aspect of the aortic valve, combined with a low level of anticoagulation, favors thrombosis at this site. Thrombus organization leads to aortic stenosis of variable severity. This previously unsuspected complication was not detected clinically in any of our patients. Aortic stenosis may hold serious implications for patients in whom the LVAD acts as a bridge to recovery or in those in whom the LVAD fails. Prevention may be achieved by intermittently reducing LVAD pumping action. A built-in venting cycle would be of value in long-term implants. Thrombi on the aortic valve may also predispose patients to infective endocarditis, because bloodstream infection is common in patients with LVADs. (Ann Thorac Surg 2000;70:1270 4) 2000 by The Society of Thoracic Surgeons The left ventricular assist device (LVAD) has proved to be an effective bridge to transplantation [1 5]. It has recently been shown that the use of a LVAD has allowed some patients with dilated cardiomyopathy to recover sufficient native myocardial function to allow the pump to be removed [6, 7]. The University of Minnesota is one of the sites at which a clinical trial of LVAD (HeartMate; Thermo Cardiosystems, Inc, Woburn, MA) as an alternative to medical therapy for patients who are not transplant candidates is currently under way. Disadvantages of current mechanical devices [5, 8] include the following: a variable propensity for thromboembolic complications necessitating systemic anticoagulation (and its attendant Accepted for publication April 20, Address reprint requests to Dr Rose, Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, MMC 76, Mayo Building, 420 Delaware St SE, Minneapolis, MN 55455; rosex031@tc.umn.edu. complications), infection of the transcutaneous connections, and possible device malfunction. A low thromboembolic risk without anticoagulation using advanceddesign LVADs has been reported [9]. Nevertheless, although procoagulant and fibrinolytic pathways are apparently balanced in such patients, the presence of the LVAD leads to significant thrombin generation and corresponding fibrinolysis. This underscores the potential for the development of bleeding or thrombosis in clinically relevant settings [10]. The purpose of this communication is to draw attention to the possible development of aortic valve stenosis in recipients of LVADs and to suggest a means of preventing this potentially serious complication. Material and Methods During the period January 1995 to January 1999, 26 HeartMate LVADs have been implanted at the Fairview by The Society of Thoracic Surgeons /00/$20.00 Published by Elsevier Science Inc PII S (00)
2 Ann Thorac Surg ROSE ET AL 2000;70: LVAD-INDUCED AORTIC STENOSIS 1271 Fig 1. Heart 1. (A) Organizing fibrin thrombus unites anterior aspect of commissure between right coronary cusp (RCC; left) and noncoronary cusp (NCC; right). (B) Aortic aspect of the aortic valve shown in (A) showing the fusing commissure between RCC (left) and NCC (right). A portion of the left ventricular assist device outflow anastomosis in the aorta distal to the aortic valve is present (top). (C) Organizing intercuspal fibrin-platelet thrombus (left) and portion of RCC (right); artifactual disruption has occurred during sectioning. (Hematoxylin and eosin; 70.) University Medical Center. All patients with implants received one aspirin daily for anticoagulation, and the LVAD pump was vented once per nursing shift. Left ventricular function stayed depressed in most patients on echo assessment. The native aortic valve stayed closed during the automatic pumping mode. All hearts bearing a HeartMate LVAD, including hearts explanted at cardiac transplantation and those encountered at autopsy in the Department of Laboratory Medicine and Pathology at Fairview-University of Minnesota Medical Center during the period August 1998 to January 1999, were examined for evidence of valvular heart disease. Careful note was made of any valvular alterations. The length and nature of commissural fusion was recorded. The valves were photographed, and histologic sections were made of any valvular lesions encountered. The commissures were sectioned horizontally to include the aortic wall as well as both cusps. All valvular tissue was processed by routine paraffin embedding. Sections were stained by hematoxylin and eosin and by Verhoeff s elastic stain with a van Gieson counterstain. Table 1. Clinicopathologic Data on 5 Patients With HeartMate LVAD Patient No. Age (y) Sex Cardiac Disease Duration of LVAD Placement (d) Aortic Valve 1 52 male IHD 152 RCC and NCC joined by 14- mm organizing thrombus 2 52 male IHD 118 Normal 3 53 female DCM mm fusion of LCC/NCC and 5-mm fusion of RCC/LCC 4 46 male DCM 55 Normal 5 68 female IHD 26 2-mm fusion of LCC/NCC 6 57 male IHD 42 4-mm fusion of RCC/NCC DCM dilated cardiomyopathy; IHD ischemic heart disease; LCC left coronary cusp; LVAD left ventricular assist device; NCC noncoronary cusp; RCC right coronary cusp.
3 1272 ROSE ET AL Ann Thorac Surg LVAD-INDUCED AORTIC STENOSIS 2000;70: Results We encountered six hearts with an implanted HeartMate LVAD; three were explanted recipient hearts following cardiac transplantation, and three were autopsy hearts. Five out of the six HeartMate LVADs (those in hearts 1, 2, 3, 4, and 6) were pneumatically powered (model 1000 IP devices), and one heart (heart 5) had the HeartMate VE (vented electrical) model. Clinicopathologic data are given in Table 1 and Figures 1, 2, and 3. Morphologic evidence of acquired aortic valvular disease (Table 1) was encountered in four of the six hearts that had been linked to a LVAD during life. The extent of the commissural fusion (which was purely fibrous in 3 patients and was a mixture of fibrous and organizing thrombus in 1 patient) is indicated in Table 1. Mean length of commissural fusion was 5.4 mm (range, 2 to 14 mm; SD 5.0 mm). No correlation was found between the duration of LVAD implantation and the generation of aortic valve thrombosis and commissural fusion. Mean duration of implantation of the six LVADs was days (range, 26 to 689 days; SD days). The LVADs in the 3 patients with firm, fibrous union of the affected commissures had been implanted for days (range, 26 to 689 days; SD days). Patient 1, whose device had been implanted for the second longest period (152 days) showed a greater (14 mm) extent of cuspal apposition by an organizing intercuspal thrombus that had been deposited on the ventricular aspect of the left coronary and noncoronary cusps (Fig 1). Patient 3 was a woman with dilated cardiomyopathy whose LVAD had been implanted for 689 days. Her myocardial function had improved in the interim, and the patient had been discharged from hospital, but the LVAD had to be removed because of drive-line sepsis. A month later the patient suddenly collapsed at home, was partially resuscitated, and died shortly thereafter. Autopsy revealed fusion of two com- Fig 2. Heart 3. (A) Fibrous fusion of commissure between left coronary cusp and noncoronary cusp (next to forceps). The fusion between the right coronary and left coronary cusps was disrupted before photography. (B) Histologic section of fused portion of left coronary and noncoronary cusps. The original valve cusps appear dark red, and the intervening area of fusion appears paler and represents less dense, more recently formed collagen, probably due to organization of an intercuspal fibrin deposit. (Elastic van Gieson stain; 20.) Fig 3. Heart 5. Macroscopic appearance of healed, fibrous commissural fusion between left coronary cusp (right, held by forceps) and noncoronary (left) cusp of aortic valve.
4 Ann Thorac Surg ROSE ET AL 2000;70: LVAD-INDUCED AORTIC STENOSIS 1273 Fig 4. (A) Healed, fibrous commissural fusion of two aortic valve cusps in an additional patient not discussed in the article, whose LVAD had been implanted for 165 days (see Addendum). (B) Transverse section of fused commissure. (Elastic van Gieson stain; 20.) missures of her aortic valve (Fig 2). Because the valvular complication had been unsuspected, the echocardiogram performed just before removal of the LVAD had not specifically visualized the aortic valvular commissures, nor had it measured aortic valve gradients. Patient 5, whose device had been implanted for the shortest period (26 days), showed healed, fibrous fusion of a single commissure (Fig 3). Comment A recent comprehensive review of implantable LVADs [11] lists only the following as possible complications of LVADs: (1) the most common early complications are bleeding, right-sided heart failure, air embolism, and progressive multisystem organ failure; and (2) the most common late complications are infection, thromboembolism, and device failure. Although the review discusses hemodynamic features of the blood flow in LVAD recipients with various valvular lesions, no mention is made of any valvular complications in the native heart resulting from the LVAD. It was recommended that patients with preexisting mitral stenosis or aortic regurgitation may require correction of the valvulopathy before implantation of a LVAD [11]. As far as we are aware, there has been no previous report describing aortic valve pathology induced by a LVAD. The development of aortic stenosis will have a less deleterious effect in patients scheduled for biological cardiac transplantation, but it holds potentially serious implications for the following populations: (1) patients in whom the LVAD is aimed to serve as a bridge to recovery [6], and (2) patients whose device fails. Muller and colleagues [6] have described 5 patients with idiopathic dilated cardiomyopathy treated with long-term LVAD therapy who were successfully weaned from mechanical support. The wearable electrical devices currently available have external backup mechanisms to continue temporary support [11, 12]. If the backup mechanism should not be available or fail, the native heart must provide systemic support until the device can be repaired. Under such circumstances, the presence of significant aortic stenosis could have highly unfavorable effects on the function of a diseased left ventricle that has not been called upon to support the full circulation for many months or years.
5 1274 ROSE ET AL Ann Thorac Surg LVAD-INDUCED AORTIC STENOSIS 2000;70: When set in the automatic mode, the HeartMate LVAD automatically ejects when it reaches 90% of filling capacity. This keeps the left ventricle unloaded, and the aortic valve remains permanently closed [13]. Stasis of blood on the ventricular aspect of the permanently immobilized aortic valve cusps (more particularly in the commissural region), combined with low anticoagulation, favors development of thrombi in this region. Increased thrombin generation in patients with LVAD acts as an additional factor favoring thrombosis. Thrombi are unlikely to form on the aortic aspect of the aortic valve or in the sinuses of Valsalva, which are washed by blood pumped in from the LVAD. The native aortic valve will only open when pressure in the left ventricle exceeds that in the ascending aorta, as happens, for example, during the regular cycle of venting the pneumatically powered drive line or during exercise. With exercise (a rare event in patients with LVADs), increased preload results in a more forceful left ventricular contraction and in Doppler evidence of significant flow across the native aortic valve [14, 15]. Organization of such thrombus leads to commissural fusion and acquired aortic stenosis. The severity of the latter will depend on the number and extent of the aortic valvular commissural fusions. Fusion of a single commissure leads to an acquired bicuspid aortic valve (as seen in heart 1 and, to a lesser extent, in heart 5). Fusion of two commissures was observed in heart 3. Fusion of all three commissures, which was not observed in this study, may also be predicted to occur. The aortic valvular stenosis resulting from the LVAD is easily distinguishable from senile calcific aortic stenosis, which does not produce commissural fusion and shows cuspal calcification [16]. Chronic rheumatic aortic stenosis shows commissural fusion, but the valve cusps are diffusely thickened, fibrosed, and vascularized and may show inflammation. The mitral valve is also usually affected in patients with rheumatic aortic stenosis. In aortic stenosis associated with LVAD-induced commissural fusion, the aortic leaflets appear normal apart from the commissural fusion. Infection is common in patients with implanted LVADs. In the series reported by McCarthy and colleagues [17], 55% of patients had bloodstream infection during LVAD support. The presence of thrombus on the aortic valve may predispose to infective endocarditis, the pathogenesis of which involves infection of a preexisting bland valvular thrombus. In future clinical examination of patients with LVADs, we shall be paying particular attention to the native aortic valve. In theory, thrombi on the aortic valve cusps and partial commissural fusion may be prevented by allowing intermittent opening of the aortic valve by left ventricular systole, induced by periodic venting of the LVAD. A built-in pump-venting cycle would be of value in long-term implants. Addendum Subsequent to the submission of this manuscript, we have encountered 3 additional patients with partial aortic valve commissural fusion associated with the presence of a LVAD. The heart of 1 of these patients, who had a LVAD for 165 days, is illustrated in Figure 4. References 1. De Vries WC, Anderson JL, Joyce LD, et al. Clinical use of the total artificial heart. N Engl J Med 1984;310: Griffith BP, Hardesty RL, Kormos RL, et al. Temporary use of the Jarvik-7 total artificial heart before transplantation. N Engl J Med 1987;316: Portner PM, Oyer PE, Pennington DG, et al. Implantable left ventricular assist system: bridge to transplant and the future. Ann Thorac Surg 1989;47: Kormos RL, Murali S, Dew MA, et al. Chronic mechanical circulatory support, rehabilitation, low morbidity, and superior survival. Ann Thorac Surg 1994;57: Hunt SA. Current status of cardiac transplantation. JAMA 1998;280: Muller J, Wallukat G, Weng Y-G, et al. Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation 1997;96: Rose EA, Frazier OH. Resurrection after mechanical circulatory support. Circulation 1997;96: Scott-Burden T, Tock CL, Bosley JP, Schwarz JJ, Engler DA, Casscells SW. Genetically engineered cellular linings for ventricular assist devices [Abstract]. Cardiovasc Pathol 1998;7: Slater JP, Rose EA, Levin HR, et al. Low thromboembolic risk without anticoagulation using advanced-design left ventricular assist devices. Ann Thorac Surg 1996;62: Spanier T, Oz M, Levin H, et al. Activation of coagulation and fibrinolytic pathways in patients with left ventricular assist devices. J Thorac Cardiovasc Surg 1996;112: Goldstein DJ, Oz MC, Rose EA. Implantable left ventricular assist devices. N Engl J Med 1998;339: Rose EA, Goldstein DJ. Wearable long-term mechanical support for patients with end-stage heart disease: a tenable goal. Ann Thorac Surg 1996;61: McCarthy PM, Nakatani S, Vargo R, et al. Structural and ventricular histologic changes after implantable LVAD insertion. Ann Thorac Surg 1995;59: Branch KR, Dembitsky WP, Peterson KL, et al. Physiology of the native heart and Thermo Cardiosystems left ventricular assist device complex at rest and during exercise: implications for chronic support. J Heart Lung Transplant 1994;13: Jaski BE, Branch KR, Adamson R, et al. Exercise hemodynamics during long-term implantation of a left ventricular assist device in patients awaiting heart transplantation. J Am Coll Cardiol 1993;22: Rose AG. Etiology of valvular heart disease. Curr Opinion Cardiol 1996;11: McCarthy PM, Schmitt SK, Vargo RL, Gordon S, Keys TF, Hobbs RE. Implantable LVAD infections: implications for permanent use of the device. Ann Thorac Surg 1996;61:
Evaluation of Native Left Ventricular Function During Mechanical Circulatory Support.: Theoretical Basis and Clinical Limitations
Review Evaluation of Native Left Ventricular Function During Mechanical Circulatory Support.: Theoretical Basis and Clinical Limitations Tohru Sakamoto, MD, PhD Left ventricular function on patients with
More informationCalcified Aortic Sinotubular Ridge: A Source of Coronary Ostial Stenosis or Embolism
1510 JACC Vol. 12, No, 6 December 1988:1510--4 Calcified Aortic Sinotubular Ridge: A Source of Coronary Ostial Stenosis or Embolism KEVIN J. TVETER, MD, JESSE E. EDWARDS, MD, FACC St, Paul, Minnesota This
More informationModern Left Ventricular Assist Devices (LVAD) : An Intro, Complications, and Emergencies
Modern Left Ventricular Assist Devices (LVAD) : An Intro, Complications, and Emergencies ERIC T. ROME D.O. HEART FAILURE, MECHANICAL ASSISTANCE AND TRANSPLANTATION CVI Left Ventricular Assist Device An
More informationImplantable Left Ventricular Assist Devices Provide an Excellent Outpatient Bridge to Transplantation and Recovery
1773 Implantable Left Ventricular Assist Devices Provide an Excellent Outpatient Bridge to Transplantation and Recovery JOSEPH J. DEROSE, JR., MD, JUAN P. UMANA, MD, MICHAEL ARGENZIANO, MD, KATHARINE A.
More informationFunctional anatomy of the aortic root. ΔΡΟΣΟΣ ΓΕΩΡΓΙΟΣ Διεσθσνηής Καρδιοθωρακοτειροσργικής Κλινικής Γ.Ν. «Γ. Παπανικολάοσ» Θεζζαλονίκη
Functional anatomy of the aortic root ΔΡΟΣΟΣ ΓΕΩΡΓΙΟΣ Διεσθσνηής Καρδιοθωρακοτειροσργικής Κλινικής Γ.Ν. «Γ. Παπανικολάοσ» Θεζζαλονίκη What is the aortic root? represents the outflow tract from the LV provides
More informationMitral Valve Disease, When to Intervene
Mitral Valve Disease, When to Intervene Swedish Heart and Vascular Institute Ming Zhang MD PhD Interventional Cardiology Structure Heart Disease Conflict of Interest None Current ACC/AHA guideline Stages
More informationMATRIX VHD FORM. State the name of the patient ( Product Recipient ) for whom you are providing the information contained in this form.
MATRIX VHD FORM A. Patient Information State the name of the patient ( Product Recipient ) for whom you are providing the information contained in this form. (First Name) (Middle Initial) (Last Name) (Date
More informationLeft Ventricular Assist Devices (LVADs): Overview and Future Directions
Left Ventricular Assist Devices (LVADs): Overview and Future Directions FATIMA KARAKI, M.D. PGY-3, DEPARTMENT OF MEDICINE WASHINGTON UNIVERSITY IN ST. LOUIS ST. LOUIS, MISSOURI, USA St. Louis, Missouri,
More informationIn contrast to aortic stenosis, which essentially has 3
Valvular Heart Disease Causes of Pure Aortic Regurgitation in Patients Having Isolated Aortic Valve Replacement at a Single US Tertiary Hospital (1993 to 2005) William Clifford Roberts, MD; Jong Mi Ko,
More informationAutologous Pulmonary Valve Replacement of the Diseased Aortic Valve
Autologous Pulmonary Valve Replacement of the Diseased Aortic Valve By L. GONZALEZ-LAvIN, M.D., M. GEENS. M.D., J. SOMERVILLE, M.D., M.R.C.P., ANm D. N. Ross, M.B., CH.B., F.R.C.S. SUMMARY Living tissue
More informationBy the end of this session, the student should be able to:
Valvular Heart disease HVD By Dr. Ashraf Abdelfatah Deyab VHD- Objectives By the end of this session, the student should be able to: Define and classify valvular heart disease. Enlist the causes of acquired
More informationLeft ventricular assist devices (LVAD) have been demonstrated
Is Severe Right Ventricular Failure in Left Ventricular Assist Device Recipients a Risk Factor for Unsuccessful Bridging to Transplant and Post-Transplant Mortality Jeffrey A. Morgan, MD, Ranjit John,
More informationLVAD Complications, Recovery
LVAD Complications, Recovery Abbas Ardehali, M.D., F.A.C.S. Professor of Surgery and Medicine, Division of Cardiac Surgery William E. Connor Chair in Cardiothoracic Transplantation Director, UCLA Heart,
More informationAortic Insufficiency: How Often Does It Occur and When To Treat
Aortic Insufficiency: How Often Does It Occur and When To Treat Simon Maltais, MD PhD Vice-Chair of Clinical Practice Director of MCS Program Department of Cardiovascular Surgery Mayo Clinic, Rochester,
More informationChapter 24: Diagnostic workup and evaluation: eligibility, risk assessment, FDA guidelines Ashwin Nathan, MD, Saif Anwaruddin, MD, FACC Penn Medicine
Chapter 24: Diagnostic workup and evaluation: eligibility, risk assessment, FDA guidelines Ashwin Nathan, MD, Saif Anwaruddin, MD, FACC Penn Medicine Mitral regurgitation, regurgitant flow between the
More informationThe Balancing Act Bleeding and Thrombosis in MCS. Muhammad Adil Soofi
The Balancing Act Bleeding and Thrombosis in MCS Muhammad Adil Soofi Road Map Survival and complications with LVAD What is the Burden of thrombosis and bleeding Why Bleeding and Thrombosis happen When
More informationImproved Mechanical Reliability of the HeartMate XVE Left Ventricular Assist System
Improved Mechanical Reliability of the HeartMate XVE Left Ventricular Assist System Francis D. Pagani, MD, PhD, James W. Long, MD, PhD, Walter P. Dembitsky, MD, Lyle D. Joyce, MD, PhD, and Leslie W. Miller,
More informationDiagnosis of Device Thrombosis
Diagnosis of Device Thrombosis Andrew Civitello MD, FACC Medical Director, Heart Transplant Program Director, Fellowship Co-Director, Baylor St. Luke's Medical Center / Texas Heart Institute Trends in
More informationMechanical Circulatory Support in the Management of Heart Failure
Mechanical Circulatory Support in the Management of Heart Failure Feras Bader, MD, MS, FACC Associate Professor of Medicine Director, Heart Failure and Transplant Cleveland Clinic Abu Dhabi Chairman, Heart
More informationPossible link with isolated aortic stenosis
British Heart Journal, 1977, 39, 1006-1011 Minor congenital variations of cusp size in tricuspid aortic valves Possible link with isolated aortic stenosis F. E. M. G. VOLLEBERGH AND A. E. BECKER From the
More informationUNIVERSITY OF UTAH HEALTH CARE HOSPITALS AND CLINICS
UNIVERSITY OF UTAH HEALTH CARE HOSPITALS AND CLINICS CARDIAC MECHANICAL SUPPORT PROGRAM GUIDELINES CARDIAC MECHANICAL SUPPORT: LVAD BASICS FREQUENT SCENARIOS AND TROUBLESHOOTING Review Date: July 2011
More informationOutcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease
Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease TIRONE E. DAVID, MD ; SEMIN THORAC CARDIOVASC SURG 19:116-120c 2007 ELSEVIER INC. PRESENTED BY INTERN 許士盟 Mitral valve
More informationACTIVATION OF COAGULATION AND FIBRINOLYTIC PATHWAYS IN PATIENTS WITH LEFT VENTRICULAR ASSIST DEVICES
ACTIVATION OF COAGULATION AND FIBRINOLYTIC PATHWAYS IN PATIENTS WITH LEFT VENTRICULAR ASSIST DEVICES Talia Spanier, MD a Mehmet Oz, MD a Howard Levin, MD b Alan Weinberg, MS c Kathy Stamatis, MS c David
More informationAdult Echocardiography Examination Content Outline
Adult Echocardiography Examination Content Outline (Outline Summary) # Domain Subdomain Percentage 1 2 3 4 5 Anatomy and Physiology Pathology Clinical Care and Safety Measurement Techniques, Maneuvers,
More informationVentricular Assisting Devices in the Cathlab. Unrestricted
Ventricular Assisting Devices in the Cathlab Unrestricted What is a VAD? A single system device that is surgically attached to the left ventricle of the heart and to the aorta for left ventricular support
More informationComparison of Exercise Performance in Patients With Chronic Severe Heart Failure Versus Left Ventricular Assist Devices
Comparison of Exercise Performance in Patients With Chronic Severe Heart Failure Versus Left Ventricular Assist Devices Donna Mancini, MD; Rochelle Goldsmith, PhD; Howard Levin, MD; Ainat Beniaminovitz,
More informationThe Role Of Decellularized Valve Prostheses In The Young Patient
The Role Of Decellularized Valve Prostheses In The Young Patient Francisco Diniz Affonso da Costa Human Tissue Bank PUCPR - Brazil Disclosures Ownership and patent license of the SDS decellularization
More informationIn congestive heart failure, the main goal of treatment is
Left Ventricular Assist System as a Bridge to Myocardial Recovery O. H. Frazier, MD, and Timothy J. Myers, BS Texas Heart Institute at St. Luke s Episcopal Hospital, Houston, Texas Background. Despite
More informationBicuspid aortic root spared during ascending aorta surgery: an update of long-term results
Short Communication Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results Marco Russo, Guglielmo Saitto, Paolo Nardi, Fabio Bertoldo, Carlo Bassano, Antonio Scafuri,
More informationExpanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated?
Expanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated? RM Suri, V Sharma, JA Dearani, HM Burkhart, RC Daly, LD Joyce, HV Schaff Division of Cardiovascular Surgery, Mayo Clinic, Rochester,
More informationPulmonary Valve Replacement
Pulmonary Valve Replacement with Fascia Lata J. C. R. Lincoln, F.R.C.S., M. Geens, M.D., M. Schottenfeld, M.D., and D. N. Ross, F.R.C.S. ABSTRACT The purpose of this paper is to describe a technique of
More informationTwo semilunar valves. Two atrioventricular valves. Valves of the heart. Left atrioventricular or bicuspid valve Mitral valve
The Heart 3 Valves of the heart Two atrioventricular valves Two semilunar valves Right atrioventricular or tricuspid valve Left atrioventricular or bicuspid valve Mitral valve Aortic valve Pulmonary valve
More informationAortic root reconstructive surgery - new created technique for aortic stenosis
Aortic root reconstructive surgery - new created technique for aortic stenosis Reconstructive surgery of the aortic root Academician d-r Zan Mitrev, T.Anguseva, E.Stoicovski, E Idoski Special hospital
More informationA Two-Year Experience with Supported
THE ANNALS OF THORACIC SURGERY Journal of The Society of Thoracic Surgeons and the Southern Thoracic Surgical Association VOLUME 13 * NUMBER 2 - FEBRUARY 19 72 A Two-Year Experience with Supported Autologous
More informationDISCLOSURE. Echocardiography in Systemic Diseases: Questions. Relevant Financial Relationship(s) None. Off Label Usage None 5/7/2018
Echocardiography in Systemic Diseases: Questions Sunil Mankad, MD, FACC, FCCP, FASE Associate Professor of Medicine Mayo Clinic College of Medicine Director, Transesophageal Echocardiography Associate
More informationPercutaneous Cardiopulmonary Support after Acute Myocardial Infarction at the Left Main Trunk
Original Article Percutaneous Cardiopulmonary Support after Acute Myocardial Infarction at the Left Main Trunk Takashi Yamauchi, MD, PhD, 1 Takafumi Masai, MD, PhD, 1 Koji Takeda, MD, 1 Satoshi Kainuma,
More informationIs it time to consider a HEARTMATE LEFT VENTRICULAR ASSIST DEVICE (LVAD)?
Is it time to consider a HEARTMATE LEFT VENTRICULAR ASSIST DEVICE (LVAD)? A treatment for advanced heart failure. LAURA HeartMate II LVAD Recipient What is HEART FAILURE? Heart failure sometimes called
More informationThe stentless bioprosthesis has many salient features that
Aortic Valve Replacement with the Medtronic Freestyle Xenograft Using the Subcoronary Implantation Technique D. Michael Deeb, MD The stentless bioprosthesis has many salient features that make it an attractive
More informationConflict of Interests
Introduction to Interventional Echocardiography Roberto M Lang, MD Tomtec Conflict of Interests Research Grants Philips Medical Imaging Research Grants Speakers bureau Advisory bureau 1 Structural Heart
More informationDecellularization of Aortic Homografts: South American and European Current Experience
Department of Cardiac Surgery Instituto de Neurologia e Cardiologia de Curitiba (INC-Cardio) Decellularization of Aortic Homografts: South American and European Current Experience Francisco Diniz Affonso
More informationNew Cardiovascular Devices and Interventions: Non-Contrast MRI for TAVR Abhishek Chaturvedi Assistant Professor. Cardiothoracic Radiology
New Cardiovascular Devices and Interventions: Non-Contrast MRI for TAVR Abhishek Chaturvedi Assistant Professor Cardiothoracic Radiology Disclosure I have no disclosure pertinent to this presentation.
More informationHEARTMATE 3 LVAD WITH FULL MAGLEV FLOW TECHNOLOGY THEIR FUTURE STARTS WITH YOU
HEARTMATE 3 WITH FULL MAGLEV FLOW TECHNOLOGY THEIR FUTURE STARTS WITH YOU HEARTMATE 3 with Full MagLev Flow Technology HEARTMATE 3 DELIVERS UNPRECEDENTED * SURVIVAL AND SAFETY OUTCOMES **1 LANDMARK SURVIVAL
More informationI still experimental, but their use as a bridge to heart
Preperitoneal Insertion of the HeartMate 1000 IP Implantable Left Ventricular Assist Device Patrick M. McCarthy, MD, Nan Wang, MD, and Rta Vargo, MSN, RN Department of Thoracic and Cardiovascular Surgery,
More informationAndrzej Ochala, MD Medical University of Silesia, Katowice, Poland
Andrzej Ochala, MD Medical University of Silesia, Katowice, Poland Bicuspid aortic valve o Most common congenital heart disease in adults (1% - 2%) o AS is the most common complication of BAV o Patophysiology
More informationUseful? Definition of High-risk? Pre-OP/Intra-OP/Post-OP? Complication vs Benefit? Mortality? Morbidity?
Preoperative intraaortic balloon counterpulsation in high-risk CABG Stefan Klotz, M.D. Preoperative IABP in high-risk CABG Questions?? Useful? Definition of High-risk? Pre-OP/Intra-OP/Post-OP? Complication
More informationThe clinical problem of atrioventricular valve regurgitation
Mitral Regurgitation in Congenital Heart Defects: Surgical Techniques for Reconstruction Richard G. Ohye Mitral valve regurgitation (MR) is an important source of morbidity and mortality worldwide. While
More informationRheumatic heart disease
Rheumatic heart disease What will we discuss today? Etiology and epidemiology of rheumatic heart disease Pathogenesis of rheumatic heart disease Morphological changes in rheumatic heart disease Clinical
More information(Ann Thorac Surg 2008;85:845 53)
I Made Adi Parmana The utility of intraoperative TEE has become increasingly more evident as anesthesiologists, cardiologists, and surgeons continue to appreciate its potential application as an invaluable
More informationFrom the Utah Artificial Heart Program, Intermountain Medical Center, Murray, Utah.
http://www.jhltonline.org A novel non-invasive method to assess aortic valve opening in HeartMate II left ventricular assist device patients using a modified Karhunen-Loève transformation Corey J. Bishop,
More informationEcho Emergencies. Outline. Michael H. Picard, MD Massachusetts General Hospital Harvard Medical School No disclosures
Echo Emergencies Michael H. Picard, MD Massachusetts General Hospital Harvard Medical School No disclosures Outline Common emergency / on call scenarios Tamponade Pulmonary embolism/rv strain Cardiogenic
More informationLeft Ventricular Assist Device: What Should I Report?
2017 SOTA, Tucson, AZ February 21, 2017 11:15 11:40 AM 25 min Left Ventricular Assist Device: What Should I Report? Muhamed Sarić MD, PhD, MPA Director of Noninvasive Cardiology Echo Lab Associate Professor
More informationDestination Therapy SO MUCH DATA IN SUCH A SMALL DEVICE. HeartWare HVAD System The ONLY intrapericardial VAD approved for DT.
DT Destination Therapy SO MUCH DATA IN SUCH A SMALL DEVICE. HeartWare HVAD System The ONLY intrapericardial VAD approved for DT. ONLY WE HAVE THIS BREADTH OF CLINICAL EVIDENCE TO SUPPORT DESTINATION THERAPY.
More informationCoronary Artery from the Wrong Sinus of Valsalva: A Physiologic Repair Strategy
Coronary Artery from the Wrong Sinus of Valsalva: A Physiologic Repair Strategy Tom R. Karl, MS, MD he most commonly reported coronary artery malformation leading to sudden death in children and young
More informationLIVING A MORE ACTIVE LIFE. with the HeartMate 3 LVAD for the treatment of advanced heart failure RON. Recipient
LIVING A MORE ACTIVE LIFE with the HeartMate 3 LVAD for the treatment of advanced heart failure RON HeartMate 3 LVAD Recipient What is HEART FAILURE? Heart failure sometimes called a weak heart occurs
More informationUnusual Causes of Aortic Regurgitation. Case 1
Unusual Causes of Aortic Regurgitation Judy Hung, MD Cardiology Division Massachusetts General Hospital Boston, MA No Disclosures Case 1 54 year old female with h/o cerebral aneurysm and vascular malformation
More informationMulticenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy with HeartMate 3 (MOMENTUM 3) Long Term Outcomes
Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy with (MOMENTUM 3) Long Term Outcomes Mandeep R. Mehra, MD, Daniel J. Goldstein, MD, Nir Uriel, MD, Joseph
More information14 Valvular Stenosis
14 Valvular Stenosis 14-1. Valvular Stenosis unicuspid valve FIGUE 14-1. This photograph shows severe valvular stenosis as it occurs in a newborn. There is a unicuspid, horseshoe-shaped leaflet with a
More informationAdult Cardiac Surgery
Adult Cardiac Surgery Mahmoud ABU-ABEELEH Associate Professor Department of Surgery Division of Cardiothoracic Surgery School of Medicine University Of Jordan Adult Cardiac Surgery: Ischemic Heart Disease
More informationHEARTMATE II LEFT VENTRICULAR ASSIST SYSTEM. HeartMate II Left Ventricular Assist Device
HEARTMATE II LEFT VENTRICULAR ASSIST SYSTEM HeartMate II Left Ventricular Assist Device HeartMate II Left Ventricular Assist Device UNPARALLELED REAL-WORLD EXPERIENCE Over 25,000 heart failure patients
More informationEcho in Heart Failure
Echo in Heart Failure Karima Addetia, MD Heart Failure: Definition A clinical syndrome that results from impairment of ventricular filling or ejection of blood. Manifestations include dyspnea and fatigue,
More informationDetailed Order Request Checklists for Cardiology
Next Generation Solutions Detailed Order Request Checklists for Cardiology 8600 West Bryn Mawr Avenue South Tower Suite 800 Chicago, IL 60631 www.aimspecialtyhealth.com Appropriate.Safe.Affordable 2018
More informationArtificial Heart Program
Artificial Heart Program Provider Review: General VAD Overview Indications for VAD Bridge to transplant (BTT) historically most common (~80%) allow rehab from severe CHF while awaiting donor Bridge to
More informationRegurgitant Lesions. Bicol Hospital, Legazpi City, Philippines July Gregg S. Pressman MD, FACC, FASE Einstein Medical Center Philadelphia, USA
Regurgitant Lesions Bicol Hospital, Legazpi City, Philippines July 2016 Gregg S. Pressman MD, FACC, FASE Einstein Medical Center Philadelphia, USA Aortic Insufficiency Valve anatomy and function LVOT and
More informationHEARTMATE 3 LEFT VENTRICULAR ASSIST SYSTEM
HEARTMATE 3 LEFT VENTRICULAR ASSIST SYSTEM A New Milestone in LVAD Therapy HeartMate 3 Left Ventricular Assist Device Introducing the new HEARTMATE 3 LVAD WITH FULL MAGLEV FLOW TECHNOLOGY HeartMate 3 LVAD
More informationCongenital. Unicuspid Bicuspid Quadricuspid
David Letterman s Top 10 Aortic Stenosis The victim can be anyone: Echo is the question and the answer!!!! Hilton Head Island Echocardiography Conference 2012 Timothy E. Paterick, MD, JD, MBA Christopher
More informationAn anterior aortoventriculoplasty, known as the Konno-
The Konno-Rastan Procedure for Anterior Aortic Annular Enlargement Mark E. Roeser, MD An anterior aortoventriculoplasty, known as the Konno-Rastan procedure, is a useful tool for the cardiac surgeon. Originally,
More informationIntroducing the COAPT Trial
physician INFORMATION Eligible patients Symptomatic functional mitral regurgitation 3+ Not suitable candidates for open mitral valve surgery NYHA functional class II, III, or ambulatory IV Introducing
More informationDirect Oral Anticoagulant Use in Valvular Atrial Fibrillation
Direct Oral Anticoagulant Use in Valvular Atrial Fibrillation September 14, 2018 Nina Maguire, PharmD PGY1 Pharmacy Resident Seton Healthcare Family Christina.maguire@ascension.org ASCENSION TEXAS Direct
More informationThe leading implantable circulatory support technology
Advanced Mechanical Circulatory Support With the HeartMate Left Ventricular Assist Device in the Year 2000 James W. Long, MD Utah Artificial Heart Program, LDS Hospital, Salt Lake City, Utah This paper
More informationIndications and Late Results of Aortic Valve Repair
Indications and Late Results of Aortic Valve Repair Prof. Gebrine El Khoury Department of Cardiovascular and Thoracic Surgery Cliniques St. Luc Brussels, Belgium Aortic Valve Repair Question # 1 Can the
More informationBRING LIVING BACK TO LIFE. An Educational Booklet for Recipients of the Abbott Portico Transcatheter Aortic Valve
BRING LIVING BACK TO LIFE An Educational Booklet for Recipients of the Abbott Portico Transcatheter Aortic Valve TABLE OF CONTENTS Your role in the management of your health is very important. This information
More informationTHROMBOSIS. Dr. Nisreen Abu Shahin Assistant Professor of Pathology Pathology Department University of Jordan
THROMBOSIS Dr. Nisreen Abu Shahin Assistant Professor of Pathology Pathology Department University of Jordan NORMAL BLOOD VESSEL HISTOLOGY THROMBOSIS Pathogenesis (called Virchow's triad): 1. Endothelial*
More informationICE: Echo Core Lab-CRF
APPENDIX 1 ICE: Echo Core Lab-CRF Study #: - Pt Initials: 1. Date of study: / / D D M M M Y Y Y Y 2. Type of Study: TTE TEE 3. Quality of Study: Poor Moderate Excellent Ejection Fraction 4. Ejection Fraction
More informationLeft Ventricular Assist Device Malfunction: A Systematic Approach to Diagnosis
Journal of the American College of Cardiology Vol. 43, No. 9, 2004 2004 by the American College of Cardiology Foundation ISSN 0735-1097/04/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2003.11.055
More informationRight Ventricular Failure: Prediction, Prevention and Treatment
Right Ventricular Failure: Prediction, Prevention and Treatment 3 rd European Training Symposium for Heart Failure Cardiologists and Cardiac Surgeons University Hospital Bern June 24-25, 2016 Disclosures:
More informationRhondalyn C. McLean. 2 ND YEAR RESEARCH ELECTIVE RESIDENT S JOURNAL Volume VII, A. Study Purpose and Rationale
A Randomized Clinical Study To Compare The Intra-Aortic Balloon Pump To A Percutaneous Left Atrial-To-Femoral Arterial Bypass Device For Treatment Of Cardiogenic Shock Following Acute Myocardial Infarction.
More informationA Fully Magnetically Levitated Left Ventricular Assist Device. Final Report of the MOMENTUM 3 Trial
A Fully Magnetically Levitated Left Ventricular Assist Device Final Report of the MOMENTUM 3 Trial Mandeep R. Mehra, MD, Nir Uriel, MD, Joseph C. Cleveland, Jr., MD, Daniel J. Goldstein, MD, National Principal
More informationTAVR 2018: TAVR has high clinical efficacy according to baseline patient risk! ii. Con
TAVR 2018: TAVR has high clinical efficacy according to baseline patient risk! ii. Con Dimitrios C. Angouras, MD, FETCS Associate Professor of Cardiac Surgery National and Kapodistrian University of Athens,
More informationTSDA Boot Camp September 13-16, Introduction to Aortic Valve Surgery. George L. Hicks, Jr., MD
TSDA Boot Camp September 13-16, 2018 Introduction to Aortic Valve Surgery George L. Hicks, Jr., MD Aortic Valve Pathology and Treatment Valvular Aortic Stenosis in Adults Average Course (Post mortem data)
More informationImplantable LVAD Infections: Implications for Permanent Use of the Device
INFECTION Implantable LVAD Infections: Implications for Permanent Use of the Device Patrick M. McCarthy, MD, Steven K. Schmitt, MD, Rita L. Vargo, MSN, Steven Gordon, MD, Thomas F. Keys, MD, and Robert
More informationMechanical Support in the Failing Fontan-Kreutzer
Mechanical Support in the Failing Fontan-Kreutzer Stephanie Fuller MD, MS Thomas L. Spray Endowed Chair in Congenital Heart Surgery Associate Professor, The Perelman School of Medicine at the University
More informationCardiopulmonary Support and Physiology. Prediction of cardiac function after weaning from ventricular assist devices
Liang et al Cardiopulmonary Support and Physiology Prediction of cardiac function after weaning from ventricular assist devices Hong Liang, MD, a Hansheng Lin, MD, b Yuguo Weng, MD, c Michael Dandel, MD,
More informationRepair or Replacement
Surgical intervention post MitraClip Device: Repair or Replacement Saudi Heart Association, February 21-24 Rüdiger Lange, MD, PhD Nicolo Piazza, MD, FRCPC, FESC German Heart Center, Munich, Germany Division
More informationmarked increase in thickness of walls of heart in patient with HCM.
Surgical Management of Hypertrophic Obstructive Cardiomyopathy Hani K. Najm MD, Msc, FRCSC, FRCS (Glasg Glasg), FACC, FESC President of Saudi Heart Association King Abdulaziz Cardiac Centre Riyadh, Saudi
More informationORIGINAL ARTICLE. Alexander M. Bernhardt a, *, Theo M.M.H. De By b, Hermann Reichenspurner a and Tobias Deuse a. Abstract INTRODUCTION
European Journal of Cardio-Thoracic Surgery 48 (2015) 158 162 doi:10.1093/ejcts/ezu406 Advance Access publication 29 October 2014 ORIGINAL ARTICLE Cite this article as: Bernhardt AM, De By TMMH, Reichenspurner
More informationIntegrating Innovative Technologies into the Care of Cardiac Patients
Integrating Innovative Technologies into the Care of Cardiac Patients Marc J. Semigran MD Medical Director, Heart Failure & Cardiac Transplantation MGH Associate Professor Harvard Medical School Presenter
More informationLong-term results (22 years) of the Ross Operation a single institutional experience
Long-term results (22 years) of the Ross Operation a single institutional experience Authors: Costa FDA, Schnorr GM, Veloso M,Calixto A, Colatusso D, Balbi EM, Torres R, Ferreira ADA, Colatusso C Department
More informationMyocardial Infarction
Myocardial Infarction MI = heart attack Defined as necrosis of heart muscle resulting from ischemia. A very significant cause of death worldwide. of these deaths, 33% -50% die before they can reach the
More informationAnatomy of left ventricular outflow tract'
Anatomy of left ventricular outflow tract' ROBERT WALMSLEY British Heart Journal, 1979, 41, 263-267 From the Department of Anatomy and Experimental Pathology, The University, St Andrews, Scotland SUMMARY
More information7. Echocardiography Appropriate Use Criteria (by Indication)
Criteria for Echocardiography 1133 7. Echocardiography Criteria (by ) Table 1. TTE for General Evaluation of Cardiac Structure and Function Suspected Cardiac Etiology General With TTE 1. Symptoms or conditions
More informationIndications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014
Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications for cardiac catheterization Before a decision to perform an invasive procedure such
More informationLow thromboembolic risk for patients with the Heartmate II left ventricular assist device
Evolving Technology John et al Low thromboembolic risk for patients with the Heartmate II left ventricular assist device Ranjit John, MD, a Forum Kamdar, BS, a Kenneth Liao, MD, a Monica Colvin Adams,
More informationUnderstanding the Pediatric Ventricular Assist Device
Understanding the Pediatric Ventricular Assist Device W. James Parks, MSc., MD Pediatric Cardiologist Assistant Professor of Pediatrics and Radiology Children s Healthcare of Atlanta Sibley Heart Center
More informationLeft ventricular assist device as a bridge to partial left ventriculectomy 1
European Journal of Cardio-thoracic Surgery 15 (Suppl. 1) (1999) S20 S25 Left ventricular assist device as a bridge to partial left ventriculectomy 1 O.H. Frazier* Texas Heart Institute, P.O. Box 20345,
More informationTAVI- Is Stroke Risk the Achilles Heel of Percutaneous Aortic Valve Repair?
TAVI- Is Stroke Risk the Achilles Heel of Percutaneous Aortic Valve Repair? Elaine E. Tseng, MD and Marlene Grenon, MD Department of Surgery Divisions of Adult Cardiothoracic and Vascular and Endovascular
More informationCongestive Heart Failure or Heart Failure
Congestive Heart Failure or Heart Failure Dr Hitesh Patel Ascot Cardiology Group Heart Failure Workshop April, 2014 Question One What is the difference between congestive heart failure and heart failure?
More informationcan flow in the smaller artery (fig. 1). In the present
Cross-sectional Area of the Proximal Portions of the Three Major Epicardial Coronary Arteries in 98 Necropsy Patients with Different Coronary Events Relationship to Heart Weight, Age and Sex CHARLES S.
More informationTotal Endovascular Repair Type A Dissection. Eric Herget Interventional Radiology
Total Endovascular Repair Type A Dissection Eric Herget Interventional Radiology 65 year old male Acute Type A Dissection Severe Aortic Regurgitation No co-morbidities Management? Part II Evolving Global
More information